CROSS COUNTRY HEALTHCARE INC (CCRN) Stock Analyst Ratings
USA - NASDAQ:CCRN - US2274831047 - Common Stock
12.21 USD
-0.16 (-1.29%)
12.21 USD
0 (0%)
ChartMill assigns a Buy % Consensus number of 52% to CCRN. The Buy consensus is the weighted average rating of the current analysts ratings.
Analysts have set a mean price target forecast of 18.44. This target is 51.06% above the current price.
CCRN was analyzed by 13 analysts. The buy percentage consensus is at 52. So analysts seem to be rather neutral about CCRN.
In the previous month the buy percentage consensus was at a similar level.
CCRN was analyzed by 13 analysts, which is quite many. So the average rating should be quite meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2025-06-17 | Barrington Research | Maintains | Market Perform -> Market Perform |
| 2025-05-13 | UBS | Maintains | Neutral -> Neutral |
| 2025-03-14 | Barrington Research | Maintains | Market Perform -> Market Perform |
| 2025-02-06 | JMP Securities | Reiterate | Market Perform -> Market Perform |
| 2024-12-10 | Barrington Research | Downgrade | Outperform -> Market Perform |
| 2024-12-05 | Truist Securities | Maintains | Hold -> Hold |
| 2024-11-07 | Benchmark | Maintains | Buy -> Buy |
| 2024-10-21 | Truist Securities | Maintains | Hold -> Hold |
| 2024-08-08 | Barrington Research | Maintains | Outperform -> Outperform |
| 2024-08-01 | Truist Securities | Maintains | Hold -> Hold |
| 2024-05-06 | Barrington Research | Maintains | Outperform -> Outperform |
| 2024-05-02 | Benchmark | Maintains | Buy -> Buy |
| 2024-02-27 | Barrington Research | Maintains | Outperform -> Outperform |
| 2024-02-22 | Benchmark | Maintains | Buy -> Buy |
| 2024-02-22 | Truist Securities | Maintains | Hold -> Hold |
| 2023-12-06 | JMP Securities | Initiate | Market Perform |
| 2023-11-30 | UBS | Initiate | Neutral |
| 2023-11-29 | Barrington Research | Maintains | Outperform -> Outperform |
| 2023-11-03 | Truist Securities | Maintains | Hold -> Hold |
| 2023-11-03 | Jefferies | Downgrade | Buy -> Hold |
| 2023-10-05 | Jefferies | Maintains | Buy -> Buy |
| 2023-08-14 | Barrington Research | Maintains | Outperform -> Outperform |
| 2023-08-08 | Credit Suisse | Maintains | Neutral -> Neutral |
| 2023-06-26 | William Blair | Initiate | Outperform |
| 2023-06-01 | Barrington Research | Maintains | Outperform -> Outperform |
| 2023-05-05 | Credit Suisse | Maintains | Neutral |
| 2023-05-02 | Truist Securities | Maintains | Hold |
| 2023-03-10 | Loop Capital | Initiate | Buy |
| 2023-02-23 | Benchmark | Maintains | Buy |
| 2023-02-23 | Credit Suisse | Maintains | Neutral |
CROSS COUNTRY HEALTHCARE INC / CCRN FAQ
What is the average price target for CROSS COUNTRY HEALTHCARE INC (CCRN) stock?
13 analysts have analysed CCRN and the average price target is 18.44 USD. This implies a price increase of 51.06% is expected in the next year compared to the current price of 12.21.
How do analysts rate CROSS COUNTRY HEALTHCARE INC (CCRN)?
The consensus rating for CROSS COUNTRY HEALTHCARE INC (CCRN) is 52.3077 / 100 . This indicates that analysts generally have a neutral outlook on the stock.
Can you provide the analyst count for CROSS COUNTRY HEALTHCARE INC stock?
The number of analysts covering CROSS COUNTRY HEALTHCARE INC (CCRN) is 13.